INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Antony-Debre, I. [1 ,2 ]
Leite, J. [1 ]
Paul, A. [3 ]
Mitchell, K. [1 ]
Kim, H. M. [3 ]
Huang, K. [3 ]
Kumar, A. [3 ]
Farahat, A. A. [3 ]
Bartholdy, B. [1 ]
Narayanagari, S. -R. [1 ]
Carvajal, L. A. [1 ]
Chen, J. [1 ]
Ambesi-Impiombato, A. [4 ]
Ferrando, A. A. [4 ]
Mantzaris, I. [1 ]
Gavathiotis, E. [1 ]
Verma, A. [1 ]
Will, B. [1 ]
Boykin, D. W. [3 ]
Wilson, W. D. [3 ]
Poon, G. M. K. [3 ]
Steidl, U. [1 ]
机构：
[1] Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY USA
[2] Gustave Roussy, Inserm U1170, Villejuif, France
[3] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA
[4] Columbia Univ, Inst Canc Genet, New York, NY USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S135
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [31] Risk Adapted Therapeutic Strategy of Acute Myeloid Leukemia
    Mohty, Razan
    Massoud, Radwan
    Chakhachiro, Zaher
    Mahfouz, Rami
    Nassif, Samer
    Elcheikh, Jean
    Bazarbachi, Ali
    BLOOD, 2019, 134
  • [32] Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
    Nourkeyhani, Houman
    Jason, Den Haese P.
    Scott, Portwood
    Hanekamp, Diana
    Johnson, Megan
    Wang, Eunice S.
    BLOOD, 2016, 128 (22)
  • [33] Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia
    Will, Britta
    Vogler, Thomas O.
    Todorova, Tihoinira I.
    Chen, Jiahao
    Yu, Yiting
    Mayer, Jillian
    Carvajal, Luis
    Roth, Michael
    van Oers, Johanna
    Schaetzlein, Sonja
    McMahon, Christine
    Steidl, Ulrich
    BLOOD, 2015, 126 (23)
  • [34] Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice
    P Basova
    V Pospisil
    F Savvulidi
    P Burda
    K Vargova
    L Stanek
    M Dluhosova
    E Kuzmova
    A Jonasova
    U Steidl
    P Laslo
    T Stopka
    Oncogene, 2014, 33 : 4735 - 4745
  • [35] Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice
    Basova, P.
    Pospisil, V.
    Savvulidi, F.
    Burda, P.
    Vargova, K.
    Stanek, L.
    Dluhosova, M.
    Kuzmova, E.
    Jonasova, A.
    Steidl, U.
    Laslo, P.
    Stopka, T.
    ONCOGENE, 2014, 33 (39) : 4735 - 4745
  • [36] FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1
    Mishra, Mukul
    Thacker, Gatha
    Sharma, Akshay
    Singh, Anil Kumar
    Upadhyay, Vishal
    Sanyal, Sabyasachi
    Verma, Shailendra Prasad
    Tripathi, Anil Kumar
    Bhatt, Madan Lal Brahma
    Trivedi, Arun Kumar
    MOLECULAR CANCER RESEARCH, 2021, 19 (02) : 261 - 273
  • [37] Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
    Frank Rosenbauer
    Katharina Wagner
    Jeffery L Kutok
    Hiromi Iwasaki
    Michelle M Le Beau
    Yutaka Okuno
    Koichi Akashi
    Steven Fiering
    Daniel G Tenen
    Nature Genetics, 2004, 36 : 624 - 630
  • [38] Excess granulopoiesis and subsequent acute myeloid leukemia induced by complete loss of PU.1 in adult mice
    Dakic, A
    Metcalf, D
    Di Rago, L
    Mifsud, S
    Wu, L
    Nutt, SL
    TISSUE ANTIGENS, 2005, 66 (05): : 388 - 389
  • [39] Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
    Rosenbauer, F
    Wagner, K
    Kutok, JL
    Iwasaki, H
    Le Beau, MM
    Okuno, Y
    Akashi, K
    Fiering, S
    Tenen, DG
    NATURE GENETICS, 2004, 36 (06) : 624 - 630
  • [40] HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
    Liu, Lulu
    Zhang, Jingjing
    Zhang, Xianning
    Cheng, Panpan
    Liu, Lei
    Huang, Qian
    Liu, Haihui
    Ren, Saisai
    Wei, Peng
    Wang, Cuiling
    Dou, Cuiyun
    Chen, Lulu
    Liu, Xin
    Zhang, Hao
    Chen, Mingtai
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (01): : 107 - 118
12345